ICVRD-2026

April 13-15, 2026  Hotel Inn Paris CDG Airport, Paris, France
Submit Abstract Register Brochure

Topics

ICVRD-2026 provides leading forum for the presentation of new advances and research results in the fields of Vaccines Research an Development . Accordingly , Topics of interest for submission include, but are not limited to:

  • mRNA, DNA & Next-Generation Vaccine Platforms
  • COVID-19, Pandemic Vaccines & Emerging Pathogens
  • AI & Big Data in Vaccine R&D
  • Personalized Vaccines and Precision Immunotherapy
  • Next-Generation Vaccine Platforms for Personalized Delivery
  • Immune Profiling and Long COVID: Implications for Vaccine Strategies
  • New Trends in Vaccines Development
  • Economic, Market Access & Equity Issues in Vaccines
  • Reverse Vaccinology & Immunoinformatics
  • One Health and Zoonotic Diseases
  • AI and Digital Tools in Vaccine Development
  • Infectious and Non-Infectious Diseases
  • Fungal/Bacterial/Viral/Parasitic/STD vaccines
  • Pharmacovigilance & Vaccine Safety
  • Precision Vaccinology: Toward a Personalized Future
  • Cancer Vaccines and Therapeutic Immunology
  • Influenza, RSV & Respiratory Virus Combos
  • Universal Vaccines (e.g., for influenza, coronaviruses, Pan‑flu)
  • Clinical Trial Design & Human Challenge Studies
  • Nanoparticle & Virus‑like Particle Delivery Systems
  • Microneedle, Oral, Nasal & Needle‑Free Delivery
  • Community-Led Research in Vaccine Development and Public Health
  • Vaccine Hesitancy, Public Health Communication & Civil Society Engagement
  • Global Public Health & Immunization Strategies
  • Vector‑Borne/Zoonotic & “One Health” Vaccines
  • Emerging/Re-Emerging Pathogens & Pandemic Preparedness
  • Live‑Attenuated & Inactivated/Subunit Vaccines
  • Conjugate, Recombinant & Toxoid Vaccines
  • Advances in Analytical Techniques for Vaccine Quality Control
  • Fungal/Bacterial/Viral/Parasitic/STD vaccines
  • Synthetic Biology and Bioengineering Approaches in Vaccinology
  • Veterinary Vaccines & Animal Health Spillovers
  • Immunotherapy and Vaccine Approaches for Type 1 Diabetes
  • Infectious Triggers of Diabetes and Vaccine Implications
  • Pediatric & Maternal Immunization
  • Economic, Market & Access Equity Issues
  • Translational Immunology & Bench‑to‑Bedside
  • Vaccine Manufacturing, Stability & Distribution
  • Antimicrobial Resistance (AMR) Vaccines
  • Conjugate & HPV Vaccines
  • Human Vaccines & Immunotherapeutics
  • Infectious Diseases & Immunization
  • The Role of Chemistry and Quality Assurance in Vaccine Development
  • Systems Vaccinology & Biomarkers & Immunological Memory
  • Applied Science, Engineering & Technology in Modern Vaccine Development
  • Nanotechnology and Polymeric Vaccine Delivery Systems
  • Regulatory Science, Policy & Global Harmonization in Vaccine Approval
  • Cold-Chain Innovation & Sustainable Vaccine Logistics

Organized by